--- title: "12 Health Care Stocks Moving In Wednesday's Pre-Market Session" type: "News" locale: "en" url: "https://longbridge.com/en/news/290051639.md" description: "In Wednesday's pre-market session, several healthcare stocks showed significant movement. Gainers included Azitra (+86.5%), uniQure (+74.1%), and Lunai Bioworks (+63.4%). Conversely, losers featured Aditxt (-29.4%), IM Cannabis (-15.4%), and CervoMed (-11.9%). The data highlights volatility among small-cap biotech and medical device companies ahead of regular trading." datetime: "2026-06-17T12:06:05.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/290051639.md) - [en](https://longbridge.com/en/news/290051639.md) - [zh-HK](https://longbridge.com/zh-HK/news/290051639.md) generator: "portal-rs" --- # 12 Health Care Stocks Moving In Wednesday's Pre-Market Session ### Gainers - **Azitra** (AMEX:AZTR) shares rose 86.5% to $0.34 during Wednesday's pre-market session. The market value of their outstanding shares is at $2.9 million. - **uniQure** (NASDAQ:QURE) stock moved upwards by 74.1% to $46.99. The company's market cap stands at $1.7 billion. - **Lunai Bioworks** (NASDAQ:LNAI) stock increased by 63.44% to $4.65. The market value of their outstanding shares is at $12.8 million. - **NewGenIvf Group** (NASDAQ:NIVF) shares moved upwards by 40.07% to $0.98. The market value of their outstanding shares is at $1.9 million. - **ClearPoint Neuro** (NASDAQ:CLPT) shares rose 31.18% to $17.5. The market value of their outstanding shares is at $400.0 million. - **Eloxx Pharma** (NASDAQ:ELOX) shares increased by 13.72% to $14.5. The company's market cap stands at $43.8 million. ### Losers - **Aditxt** (NASDAQ:ADTX) stock declined by 29.4% to $0.01 during Wednesday's pre-market session. - **IM Cannabis** (NASDAQ:IMCC) stock declined by 15.39% to $0.22. The market value of their outstanding shares is at $2.3 million. - **CervoMed** (NASDAQ:CRVO) shares decreased by 11.87% to $3.98. The company's market cap stands at $41.8 million. - **Avalo Therapeutics** (NASDAQ:AVTX) stock declined by 11.38% to $12.7. The company's market cap stands at $753.2 million. - **iTonic Holdings** (NASDAQ:ITOC) shares declined by 11.25% to $0.31. The market value of their outstanding shares is at $6.0 million. - **bioAffinity Technologies** (NASDAQ:BIAF) stock decreased by 11.11% to $0.84. The company's market cap stands at $4.4 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/ This article was generated by Benzinga's automated content engine and reviewed by an editor. ### Related Stocks - [CRVO.US](https://longbridge.com/en/quote/CRVO.US.md) - [ADTX.US](https://longbridge.com/en/quote/ADTX.US.md) - [LNAI.US](https://longbridge.com/en/quote/LNAI.US.md) - [AZTR.US](https://longbridge.com/en/quote/AZTR.US.md) - [QURE.US](https://longbridge.com/en/quote/QURE.US.md) - [IMCC.US](https://longbridge.com/en/quote/IMCC.US.md) - [NIVF.US](https://longbridge.com/en/quote/NIVF.US.md) - [CLPT.US](https://longbridge.com/en/quote/CLPT.US.md) - [ELOX.US](https://longbridge.com/en/quote/ELOX.US.md) - [AVTX.US](https://longbridge.com/en/quote/AVTX.US.md) - [ITOC.US](https://longbridge.com/en/quote/ITOC.US.md) - [BIAF.US](https://longbridge.com/en/quote/BIAF.US.md) - [RENB.US](https://longbridge.com/en/quote/RENB.US.md) - [NIVFW.US](https://longbridge.com/en/quote/NIVFW.US.md) - [BIAFW.US](https://longbridge.com/en/quote/BIAFW.US.md) ## Related News & Research - [CervoMed Q2 net loss lower than estimates as costs drop](https://longbridge.com/en/news/295400250.md) - [The Rare Earth Mirage: The Midstream Bet Hiding in Plain Sight (NASDAQ: EMAT)](https://longbridge.com/en/news/296940044.md) - [Greenland Mines (NASDAQ: GRML) Initial Assessment Values Sarfartoq at Up to $2.05B Pre-Tax NPV](https://longbridge.com/en/news/296932902.md) - [Nuveen NASDAQ 100 Dynamic Overwrite Fund (NASDAQ:QQQX) Stock Price Up 0.3% - Here's What Happened](https://longbridge.com/en/news/296667368.md) - [Beam Therapeutics (NASDAQ:BEAM) Stock Price Up 5.8% - What's Next?](https://longbridge.com/en/news/296937626.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**